The global acute migraine drugs market is poised for steady growth, driven by increasing prevalence of migraine disorders and rising demand for effective treatment options. According to the report, the market is projected to grow at a compound annual growth rate (CAGR) of about 7% over the forecast period of 2022-2028. The market, which generated over USD 2,100 million in revenue...
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian